리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 02월
페이지 정보:영문 93 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 정형외과 연부조직 수복술 시장은 2030년까지 121억 달러에 달할 전망
2024년에 88억 달러로 추정되는 세계의 정형외과 연부조직 수복술 시장은 2024-2030년에 CAGR 5.6%로 성장하며, 2030년에는 121억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 Cruciate Ligaments Repair Procedure는 CAGR 7.2%를 기록하며, 분석 기간 종료시에는 56억 달러에 달할 전망입니다. 건판 수복술 부문의 성장률은 분석 기간 중 CAGR 4.0%로 추정됩니다.
미국 시장은 24억 달러로 추정, 중국은 CAGR 5.1%로 성장 예측
미국의 정형외과 연부조직 수복술 시장은 2024년에 24억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 19억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 5.1%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.4%와 4.3%로 예측됩니다. 유럽에서는 독일이 CAGR 4.4%로 성장할 것으로 예측됩니다.
세계의 정형외과 연부조직 수복술 시장 - 주요 동향과 촉진요인 정리
정형외과 연부조직 수복술이 스포츠 부상 및 퇴행성 질환 치료에 필수적인 이유는 무엇인가?
정형외과 연부조직 수복술은 특히 전 세계에서 스포츠 참여와 신체활동이 지속적으로 증가함에 따라 다양한 부상과 퇴행성 질환의 치료에 있으며, 매우 중요한 역할을 하고 있습니다. 힘줄, 인대, 연골 등의 연부조직은 관절을 안정시키고 움직임을 원활하게 하는 데 중요한 역할을 하지만, 반복적인 운동이나 외상, 노화에 따른 퇴행으로 인한 부상의 영향을 매우 쉽게 받게 됩니다. 건판 파열, ACL 파열, 반월상 연골판 손상 등 이러한 구조물의 손상은 운동선수나 활동적인 사람들에게 흔하게 발생하며, 완치를 위해서는 수술적 개입이 필요한 경우가 많습니다. 최소 침습적 관절경 수술부터 고급 생물학적 치료까지 정형외과 연부조직 수복술 기술은 기능 회복, 통증 완화 및 장기적인 손상을 예방하는 효과적인 솔루션을 제공합니다. 정형외과 연부조직 복원술은 이러한 중요한 구조를 복구하고 강화함으로써 환자의 이동성, 근력 및 삶의 질을 회복할 수 있도록 돕습니다.
스포츠 관련 부상이 증가함에 따라 정형외과 연부조직 수복술은 스포츠 의학의 초점이 되고 있습니다. 힘줄 및 인대 재건, 연골 재건, 반월상 연골판 재건과 같은 수술은 급성 및 만성 부상에 대처하기 위해 널리 사용되고 있으며, 환자가 재부상의 위험을 줄이면서 활동으로 복귀할 수 있도록 돕습니다. 예를 들어 ACL 재건술은 무릎의 안정성이 중요한 경기 스포츠에서 흔히 사용되는 수술입니다. 이 수술은 파열된 인대를 이식편으로 대체하여 무릎의 기능을 회복시키는 수술입니다. 마찬가지로 회전근개 복원 수술은 시간이 지남에 따라 힘줄의 마모와 파열을 유발할 수 있는 오버헤드 운동을 하는 사람들에게 자주 시행됩니다. 스포츠 참여와 피트니스에 대한 인식이 높아짐에 따라 빠르고 안전한 회복을 지원하는 전문적인 연부 조직 복구 기술에 대한 수요도 증가하고 있습니다.
정형외과 연부조직 수복술은 스포츠 손상 치료뿐만 아니라 건염, 디스크, 퇴행성관절염 등 노년층이 많이 앓고 있는 노화 관련 질환에 대한 대응에도 필수적입니다. 노화와 함께 연부조직은 탄력과 회복력을 잃어 파열과 퇴행이 일어나기 쉽습니다. 힘줄 이식, 연골 이식, 최소침습적 관절경 검사 등의 연부조직 복구 기술은 이러한 증상을 치료하고 통증을 완화하며 운동성을 회복하는 데 효과적인 옵션을 제공합니다. 급성 손상과 만성 퇴행성 질환을 모두 치료함으로써 정형외과 연부조직 복구술은 노화로 인한 관절 기능과 삶의 질에 미치는 영향을 줄여 모든 연령대의 사람들에게 종합적인 정형외과 치료의 필수적인 측면으로 자리매김하고 있습니다.
정형외과 연부조직 수복술 시장은 생물학적 치료와 혁신을 통해 어떻게 발전하고 있는가?
정형외과 연부조직 수복술 시장은 치유를 촉진하고 치료 결과를 개선하기 위한 생물학적 치료법과 기술 혁신의 등장으로 인해 큰 영향을 받고 있습니다. 혈소판풍부혈장(PRP), 줄기세포 치료, 자가 연골세포 이식(ACI)과 같은 생물학적 치료법은 손상된 연부조직을 복구하고 재생하는 새로운 접근법을 제공합니다. 환자 자신의 혈액에서 혈소판을 농축한 PRP는 성장인자에 의해 조직 회복을 촉진하기 위해 손상된 부위에 주입됩니다. 줄기세포 치료는 줄기세포를 이용하여 손상된 조직을 재생할 수 있는 가능성을 가지고 있으며, 회전근개 파열이나 연골 손상과 같은 증상에 대한 유망한 옵션을 제공합니다. 이러한 생물학적 치료는 신체의 자연 치유 과정을 촉진하여 회복 시간을 단축하고 조직 복구의 질을 향상시킬 수 있는 기존의 복구 방법을 대체할 수 있는 치료법입니다. 생물학적 치료법이 확산됨에 따라 연부조직 수복의 전망을 재구성하고 있으며, 더 빠른 회복과 흉터 감소를 원하는 환자들의 요구에 부응하는 최소침습적 재생 옵션을 제공합니다.
생물학적 치료와 더불어 수술 기술과 임플란트 재료의 혁신이 정형외과 연부조직 수복술의 발전을 주도하고 있습니다. 관절경 수술의 발전을 주도하고 있습니다. 소형 카메라와 특수기구를 사용하는 관절경 수술은 외과의사가 작은 절개창을 통해 연부조직을 복구할 수 있으며, 외상을 줄이고 회복을 가속화할 수 있습니다. 이 수술은 어깨, 무릎, 고관절의 수복에 자주 사용되어 환자의 입원 기간을 단축하고 활동 복귀를 앞당길 수 있습니다. 연부조직을 뼈에 재접합하기 위한 봉합사 앵커의 기술 혁신도 이러한 수복의 효과를 높이고 있습니다. 최신 봉합사 앵커는 고정 강도와 생체흡수성을 향상시키도록 설계되어 추가 시술의 필요성을 줄여줍니다. 생체흡수성 앵커와 전봉합사 앵커는 시간이 지남에 따라 용해되므로 장기적인 합병증을 최소화하고 자연 치유를 돕습니다. 최소침습적 시술과 생체적합성 재료가 정형외과수술의 표준이 되면서, 이러한 혁신은 외과 의사에게 성공적이고 오래 지속되는 수복을 달성할 수 있는 더 나은 수단을 제공합니다.
또한 조직 공학 및 합성 이식편은 특히 복잡하고 대규모 손상에 대한 유망한 솔루션으로 부상하고 있습니다. 폴리우레탄이나 폴리카프로락톤과 같은 재료로 만들어진 합성 이식편은 천연 조직의 구조와 기능을 모방하여 세포의 성장과 조직 재생을 지원하는 발판을 제공합니다. 예를 들어 힘줄과 인대 수복에서 합성 이식편은 자가 이식편이나 동종 이식편을 사용할 수 없을 때 대체할 수 있으며, 조직 통합을 지원하고 관절의 안정성을 향상시킬 수 있습니다. 또한 합성 소재와 생물제제를 결합한 조직공학 기술도 개발 중이며, 합성 소재의 강도와 생물학적 조직의 재생성을 융합한 하이브리드 이식편을 만드는 것을 목표로 하고 있습니다. 이러한 첨단 소재와 기술은 난치성 부상 치료에 새로운 대안을 제공하고, 연부조직 수복의 범위를 넓혀 정형외과 시장에 새로운 가능성을 열어줄 것입니다.
정형외과 연부조직 수복술이 외과의사와 환자에게 주는 장점은 무엇인가?
정형외과 연부조직 수복술은 외과의사와 환자 모두에게 많은 이점을 제공하며, 복잡한 손상에 대한 효과적인 치료를 가능하게 하고, 더 빠르고 안전한 회복을 촉진합니다. 외과의사에게 가장 큰 장점은 정확하고 최소 침습적인 시술로 관절의 안정성과 기능을 회복할 수 있다는 점입니다. 작은 절개창을 통해 수리가 가능한 관절경 기술을 통해 외과의사는 손상된 조직을 시각화하여 주변 구조물에 대한 손상을 최소화하면서 치료할 수 있습니다. 이러한 접근 방식은 수술의 정확성을 높이고, 합병증의 위험을 줄이며, 외과 의사가 큰 절개 없이도 특정 손상에 대처할 수 있게 해줍니다. 이러한 최소침습적 기술은 ACL 파열이나 건판 손상과 같은 일반적인 스포츠 손상 치료에 특히 유용하며, 표적화된 수복으로 더 나은 치료 결과와 환자의 빠른 회복을 기대할 수 있습니다. 첨단 영상 진단과 전문 툴을 사용하여 외과의사는 관절의 이동성과 기능을 완전히 회복하는 데 필수적인 정밀한 수복술을 할 수 있습니다.
정형외과 연부조직 수복술은 통증 완화, 운동성 회복, 장기적인 관절 건강 측면에서 환자들에게 큰 이점을 제공합니다. 연부조직 손상을 방치하면 만성 통증, 관절 불안정성, 일상 생활과 신체 활동에 영향을 미치는 기능적 제한을 초래할 수 있습니다. 연부조직 복구 기술을 통해 손상된 힘줄, 인대, 연골을 복구함으로써 환자는 관절의 안정성을 회복하고 통증을 완화하며 정상적인 활동으로 돌아갈 수 있습니다. 힘줄 재건 및 인대 수복과 같은 시술은 손상된 관절의 강도와 유연성을 회복하고 재부상의 위험을 줄이며 장기적인 건강을 지원합니다. 운동선수와 활동적인 사람들에게 연부 조직 복구는 더 빠른 재활을 가능하게 하고, 자신감을 가지고 스포츠와 운동에 복귀할 수 있게 해줍니다. 또한 이러한 부상을 조기에 치료하면 연부 조직 복구는 관절염을 유발하고 나중에 침습적인 수술이 필요한 관절 퇴행성 관절염의 진행을 예방할 수 있습니다.
또 다른 중요한 장점은 치유력을 높이고 회복 시간을 단축할 수 있는 생물학적 및 재생학적 접근 방식에 초점을 맞추고 있다는 점. PRP나 줄기세포 주사와 같은 생물학적 치료는 환자에게 신체의 자연적 회복 메커니즘과 함께 작동할 수 있는 옵션을 제공하고, 많은 경우 흉터를 줄이고 조직의 질을 개선하며 개선됩니다. 이러한 재생 기술은 특히 운동선수나 육체적으로 힘든 일을 하는 사람 등 신체적 요구가 높은 환자나 빠른 회복이 필요한 환자에게 특히 유용합니다. 연조직 복구에 생물제제의 사용은 보다 자연스러운 치유 과정을 지원할 뿐만 아니라, 최소침습적이고 환자 친화적인 치료에 대한 수요 증가와도 일치합니다. 생물학적 치료와 최소침습적 기술의 발전으로 정형외과 연부조직 수복술은 환자들에게 보다 안전하고 효율적인 회복 경로를 제공하여 전반적인 치료 경험과 치료 결과를 개선하고 있습니다.
정형외과 연부조직 수복술 시장의 성장을 가속하는 요인은 무엇인가?
정형외과 연부조직 수복술 시장의 성장은 스포츠 손상 발생률 증가, 고령화, 생물학적 치료 및 최소침습적 치료의 발전, 환자 중심의 치료 결과에 대한 중요성 증가 등의 요인에 기인하고 있습니다. 전 세계에서 스포츠 및 레크리에이션 활동이 활발해지면서 ACL 파열, 건판 손상, 반월상 연골판 손상과 같은 스포츠 관련 부상의 발생률이 크게 증가하고 있습니다. 이러한 부상은 종종 외과적 개입이 필요하며, 효과적이고 내구성 있는 솔루션을 제공하는 특수 연부조직 복구 기술에 대한 높은 수요가 발생하고 있습니다. 정형외과 연부조직 수복술은 이러한 수요를 충족시키는 데 필요한 툴와 기술을 제공하여 운동선수와 활동적인 사람들의 완전한 회복과 활동 복귀를 돕습니다. 또한 피트니스 및 웰빙 동향의 인기가 높아짐에 따라 연조직 손상의 위험을 증가시키는 신체 활동에 참여하는 사람들이 증가하고 있으며, 이는 시장 수요를 더욱 촉진하고 있습니다.
인구 고령화도 정형외과 연부조직 수복술 시장의 성장에 기여하는 주요 요인입니다. 나이가 들면 건염, 골관절염, 인대 손상 등 연부조직에 영향을 미치는 퇴행성 질환에 걸릴 확률이 높아집니다. 노인들은 이동성을 회복하고 통증을 완화하며 독립성을 유지하기 위해 연부조직의 수복 시술을 필요로 하는 경우가 많습니다. 특히 이 연령층에서는 건판 수복술이나 연골 수복술과 같은 시술이 흔하며, 노화로 인한 퇴행성 질환을 치료하고 노인이 활동적인 생활을 유지할 수 있도록 도와줍니다. 평균 수명이 늘어남에 따라 노년기 관절 건강과 이동성을 지원하는 솔루션에 대한 필요성이 증가함에 따라 연조직 수복에 대한 수요는 계속 증가하고 있습니다. 이러한 추세는 의료진과 환자들이 노년기에도 활동적인 라이프스타일과 높은 삶의 질을 유지하는 것을 우선순위에 두면서 더욱 확대될 것으로 예상됩니다.
또한 생물학적 치료와 최소침습적 치료의 부상도 정형외과 연부조직 수복술 시장을 촉진하고 있습니다. PRP 및 줄기세포 치료와 같은 생물학적 치료는 연부조직의 치유를 촉진하고 회복 기간을 단축할 수 있는 잠재력을 인정받고 있으며, 최신 재생 솔루션을 원하는 환자들의 기대에 부응하기 위해 최신 재생 솔루션에 대한 수요가 증가하고 있습니다. 외과 의사가 작은 절개를 통해 정밀한 수리를 할 수 있는 관절경 기술의 확대는 회복 시간을 단축하고 환자의 편안함을 향상시키는 최소 침습적 접근법에 대한 수요와 일치합니다. 이러한 혁신적인 치료법과 기술은 효과적인 결과를 가져다 줄 뿐만 아니라 환자 결과 개선에 중점을 두고 있는 의료 서비스 프로바이더에게도 매력적입니다. 스포츠 부상 증가, 고령화, 생물제제 및 최소침습 수술의 발전과 같은 요인들이 복합적으로 작용하여 정형외과 연부조직 수복술 시장은 성장을 주도하고 있으며, 현대 정형외과 및 스포츠 의학에서 중요한 분야로 자리매김하고 있습니다.
Global Orthopedic Soft Tissue Repair Market to Reach US$12.1 Billion by 2030
The global market for Orthopedic Soft Tissue Repair estimated at US$8.8 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cruciate Ligaments Repair Procedure, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Rotator Cuff Repair Procedure segment is estimated at 4.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 5.1% CAGR
The Orthopedic Soft Tissue Repair market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Why Is Orthopedic Soft Tissue Repair Essential in Treating Sports Injuries and Degenerative Conditions?
Orthopedic soft tissue repair has become critical in treating a wide range of injuries and degenerative conditions, especially as sports participation and physical activity continue to rise globally. Soft tissues, including tendons, ligaments, and cartilage, play an essential role in stabilizing joints and facilitating movement, yet they are highly susceptible to injuries from repetitive motion, trauma, and age-related degeneration. Injuries to these structures, such as rotator cuff tears, ACL ruptures, and meniscal damage, are common among athletes and active individuals and often require surgical intervention for full recovery. Orthopedic soft tissue repair techniques—ranging from minimally invasive arthroscopic surgeries to more advanced biological therapies—offer effective solutions for restoring function, reducing pain, and preventing long-term damage. By repairing and reinforcing these critical structures, orthopedic soft tissue repair supports patients in regaining mobility, strength, and quality of life.
The rising incidence of sports-related injuries has made orthopedic soft tissue repair a focal point in sports medicine, where quick and effective recovery is essential for athletes and active individuals. Procedures like tendon and ligament reconstruction, cartilage repair, and meniscal repair are widely used to address acute and chronic injuries, allowing patients to return to their activities with reduced risk of re-injury. For example, ACL reconstruction is a common procedure in competitive sports, where knee stability is crucial. This procedure uses grafts to replace the torn ligament and restore knee function, often enabling athletes to resume their performance levels. Similarly, rotator cuff repair surgeries are frequently performed in individuals who engage in overhead activities, which can lead to tendon wear and tears over time. As sports participation and fitness awareness grow, so does the demand for specialized soft tissue repair techniques that support fast, safe recovery.
In addition to treating sports injuries, orthopedic soft tissue repair is essential in addressing age-related conditions like tendinopathy, degenerative disc disease, and osteoarthritis, which commonly affect older adults. With age, soft tissues lose elasticity and resilience, making them more prone to tears and degeneration. Soft tissue repair techniques, including tendon transfers, cartilage grafting, and minimally invasive arthroscopy, provide effective options for treating these conditions, reducing pain, and restoring mobility. By addressing both acute injuries and chronic degeneration, orthopedic soft tissue repair helps mitigate the impact of aging on joint function and quality of life, positioning it as an essential aspect of comprehensive orthopedic care for people of all ages.
How Are Biological Therapies and Innovations Advancing the Orthopedic Soft Tissue Repair Market?
The orthopedic soft tissue repair market has been significantly influenced by the rise of biological therapies and technological innovations that aim to enhance healing and improve outcomes. Biological therapies, such as platelet-rich plasma (PRP), stem cell therapy, and autologous chondrocyte implantation (ACI), offer new approaches for repairing and regenerating damaged soft tissues. PRP, which involves concentrating platelets from the patient’s own blood, is injected into the injured area to promote tissue repair through growth factors. Stem cell therapy uses stem cells to potentially regenerate damaged tissue, offering a promising option for conditions like rotator cuff tears and cartilage damage. These biologic treatments provide an alternative to traditional repair methods by enhancing the body’s natural healing processes, potentially reducing recovery times and improving the quality of tissue repair. As biological therapies gain traction, they are reshaping the soft tissue repair landscape by providing minimally invasive, regenerative options that meet patient demand for faster recovery and reduced scarring.
In addition to biological therapies, innovations in surgical techniques and implant materials have driven advancements in orthopedic soft tissue repair. Arthroscopic surgery, which involves the use of a small camera and specialized instruments, allows surgeons to repair soft tissues through tiny incisions, reducing trauma and accelerating recovery. This technique is commonly used for shoulder, knee, and hip repairs, offering patients shorter hospital stays and quicker returns to activity. Innovations in suture anchors, which are used to reattach soft tissues to bone, have also enhanced the effectiveness of these repairs. Modern suture anchors are designed for improved fixation strength and bioabsorption, reducing the need for additional procedures. Bioabsorbable anchors and all-suture anchors dissolve over time, minimizing long-term complications and supporting natural healing. As minimally invasive techniques and bio-friendly materials become standard in orthopedic surgeries, these innovations are providing surgeons with better tools to achieve successful and lasting repairs.
Furthermore, tissue engineering and synthetic grafts are emerging as promising solutions for orthopedic soft tissue repair, particularly for complex or large-scale injuries. Synthetic grafts made from materials like polyurethane and polycaprolactone mimic the structure and function of natural tissues, providing scaffolding that supports cell growth and tissue regeneration. For example, in tendon and ligament repairs, synthetic grafts offer an alternative when autografts or allografts are not available, supporting tissue integration and improving joint stability. Tissue engineering techniques that combine synthetic materials with biologics are also under development, with the aim of creating hybrid grafts that blend the strength of synthetics with the regenerative potential of biological tissues. These advanced materials and techniques provide new options for treating challenging injuries, expanding the scope of soft tissue repair and opening up new opportunities in the orthopedic market.
What Are the Benefits of Orthopedic Soft Tissue Repair for Surgeons and Patients?
Orthopedic soft tissue repair offers numerous benefits for both surgeons and patients, enabling effective treatment of complex injuries while promoting faster and safer recovery. For surgeons, the primary advantage is the ability to restore joint stability and functionality through precise, minimally invasive procedures. Arthroscopic techniques, which allow repairs through small incisions, enable surgeons to visualize and treat damaged tissues with minimal disruption to surrounding structures. This approach improves surgical precision, reduces the risk of complications, and allows surgeons to address specific injuries without extensive incisions. These minimally invasive techniques are especially valuable in treating common sports injuries, such as ACL tears and rotator cuff damage, where targeted repairs lead to better outcomes and faster patient recovery. By using advanced imaging and specialized tools, surgeons can achieve highly accurate repairs, which is essential for restoring full joint mobility and function.
For patients, orthopedic soft tissue repair provides significant benefits in terms of pain relief, mobility restoration, and long-term joint health. Soft tissue injuries, if left untreated, can lead to chronic pain, joint instability, and functional limitations that affect daily life and physical activity. Repairing damaged tendons, ligaments, and cartilage through soft tissue repair techniques enables patients to regain joint stability, reduce pain, and return to their regular activities. Procedures such as tendon reconstruction and ligament repair help restore the strength and flexibility of the injured joint, reducing the risk of re-injury and supporting long-term health. For athletes and active individuals, soft tissue repair allows for quicker rehabilitation, enabling them to return to sports and exercise with confidence. Additionally, by addressing these injuries early on, soft tissue repair helps prevent the progression of joint degeneration, which can lead to arthritis and the need for more invasive surgeries later.
Another crucial benefit is the focus on biologic and regenerative approaches, which can enhance healing and reduce recovery times. Biological therapies like PRP and stem cell injections provide patients with options that work alongside the body’s natural repair mechanisms, often resulting in less scarring and improved tissue quality. These regenerative techniques are particularly beneficial for patients with high physical demands or those who require a faster recovery, such as athletes or individuals with physically demanding jobs. The use of biologics in soft tissue repair not only supports a more natural healing process but also aligns with the growing demand for minimally invasive, patient-friendly treatments. With advancements in biologic therapies and minimally invasive techniques, orthopedic soft tissue repair offers patients safer, more efficient recovery paths that improve overall treatment experiences and outcomes.
What Is Fueling the Growth in the Orthopedic Soft Tissue Repair Market?
The growth in the orthopedic soft tissue repair market is driven by factors such as the increasing incidence of sports injuries, the aging population, advancements in biologic and minimally invasive therapies, and a growing emphasis on patient-centered outcomes. As sports and recreational activities become more popular worldwide, the incidence of sports-related injuries, such as ACL tears, rotator cuff injuries, and meniscal damage, has risen significantly. These injuries often require surgical intervention, creating a high demand for specialized soft tissue repair techniques that enable effective, durable solutions. Orthopedic soft tissue repair provides the tools and techniques needed to meet this demand, helping athletes and active individuals recover fully and return to their activities. Additionally, with the increased popularity of fitness and wellness trends, more people are participating in physical activities that increase their risk of soft tissue injuries, further fueling the market demand.
The aging population is another major factor contributing to the growth of the orthopedic soft tissue repair market. As people age, they are more susceptible to degenerative conditions that affect soft tissues, such as tendinopathy, osteoarthritis, and ligament degradation. Older adults often require soft tissue repair procedures to restore mobility, reduce pain, and maintain independence. Procedures like rotator cuff repair and cartilage restoration are particularly common in this demographic, addressing age-related degeneration and helping older individuals stay active. As life expectancy increases, the need for solutions that support joint health and mobility in later years continues to drive demand for soft tissue repair. This trend is expected to grow as healthcare providers and patients prioritize maintaining an active lifestyle and high quality of life throughout aging.
The rise of biologic and minimally invasive therapies has also boosted the orthopedic soft tissue repair market, as these advancements offer less invasive, more efficient treatment options with quicker recovery times. Biological treatments such as PRP and stem cell therapy are increasingly recognized for their potential to enhance soft tissue healing and reduce recovery durations, meeting the expectations of patients seeking modern, regenerative solutions. The expansion of arthroscopic techniques, which allow surgeons to perform precise repairs through small incisions, aligns with the demand for minimally invasive approaches that reduce recovery time and improve patient comfort. These innovative therapies and techniques not only offer effective results but also appeal to healthcare providers focused on improving patient outcomes. Together, these factors—rising sports injuries, the aging population, and advancements in biologics and minimally invasive surgery—are driving the growth of the orthopedic soft tissue repair market, positioning it as a critical area within modern orthopedic and sports medicine.
SCOPE OF STUDY:
The report analyzes the Orthopedic Soft Tissue Repair market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Procedure (Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy, Other Procedures); Injury Location (Knee, Shoulder, Hip, Small Joints)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 42 Featured) -
Artelon
Arthrex
ConMed
DePuy Synthes
Integra LifeSciences
JRF Ortho
LifeNet Health
Medtronic
MTF Biologics
Parcus Medical
RTI Surgical
Smith & Nephew
Stryker
Tissue Regenix
Wright Medical
Zimmer Biomet
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Orthopedic Soft Tissue Repair - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Sports-Related Injuries Drives Soft Tissue Repair Market
Growing Preference for Minimally Invasive Surgeries Sets the Stage for Market Growth
Innovations in Biodegradable Implants Propel Demand for Soft Tissue Repair Solutions
Increasing Demand for Arthroscopic Procedures Expands Market Potential
Advancements in Biomaterials Propel Soft Tissue Repair Technologies
Rising Geriatric Population Generates Demand for Soft Tissue Repair Solutions
Increasing Use in Rotator Cuff Repair Expands Addressable Market
Growing Demand for Cartilage Repair Solutions Drives Market Growth
Increasing Investments in Sports Medicine Propel Soft Tissue Repair Demand
Soft Tissue Repair Crucial for Treatment of Tendon and Ligament Injuries
Use of Soft Tissue Repair in Trauma Surgeries Bodes Well for Market Expansion
Demand for Biocompatible Repair Materials Sets the Stage for Market Growth
Expanding Applications in Gynecological, and Urological Surgeries
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Cruciate Ligaments Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Rotator Cuff Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World Historic Review for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 12: World 15-Year Perspective for Epicondylitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 14: World Historic Review for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 15: World 15-Year Perspective for Achilles Tendinosis Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World Historic Review for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 18: World 15-Year Perspective for Pelvic Organ Prolapsed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 20: World Historic Review for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 21: World 15-Year Perspective for Hip Arthroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 24: World 15-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 26: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 27: World 15-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World Historic Review for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 30: World 15-Year Perspective for Small Joints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 32: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 33: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 35: World Historic Review for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 36: World 15-Year Perspective for Shoulder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 37: World Orthopedic Soft Tissue Repair Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Canada 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Canada 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
JAPAN
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 50: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Japan 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Japan 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
CHINA
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: China Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: China 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: China Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: China 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
EUROPE
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 62: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
FRANCE
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 71: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: France Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: France 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: France Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: France 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
GERMANY
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 77: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Germany 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 80: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Germany 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
ITALY
TABLE 83: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Italy 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 86: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Italy Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Italy 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
UNITED KINGDOM
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 89: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: UK Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: UK 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 92: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: UK Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: UK 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Rest of Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 107: Rest of World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Rest of World Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Rest of World 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
TABLE 110: Rest of World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Rest of World Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Rest of World 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
